Evidence map›Paper›PMID 36072469›Full record

ArticleBioMed research international2022

Application of Deep Learning on the Prognosis of Cutaneous Melanoma Based on Full Scan Pathology Images.

Anhai Li, Xiaoyuan Li, Wenwen Li, Xiaoqian Yu, Mengmeng Qi, Ding Li

Abstract read
In one paragraph

Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Artificial Intelligence Algorithm Predicts Response to Immune Checkpoint Inhibitors.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anhai LiDepartment of Dermatology, Qingdao Huangdao District Central Hospital, Qingdao, Shandong, China.
Xiaoyuan LiDepartment of Traditional Chinese Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.ORCID https://orcid.org/0000-0003-3305-936X
Wenwen LiDepartment of Hematology, Qingdao Women and Children's Hospital, Qingdao, Shandong, China.
Xiaoqian YuDepartment of Dermatology, Qingdao Haici Hospital (Qingdao Traditional Chinese Medicine Hospital), Qingdao, Shandong, China.
Mengmeng QiDepartment of Endocrinology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Ding LiDepartment of Dermatology, Qingdao Huangdao District Central Hospital, Qingdao, Shandong, China.ORCID https://orcid.org/0000-0002-1677-7768

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The purpose of this study is to use deep learning and machine learning to learn and classify patients with cutaneous melanoma with different prognoses and to explore the application value of deep learning in the prognosis of cutaneous melanoma patients. Methods: In deep learning, VGG-19 is selected as the network architecture and learning model for learning and classification. In machine learning, deep features are extracted through the VGG-19 network architecture, and the support vector machine (SVM) model is selected for learning and classification. Compare and explore the application value of deep learning and machine learning in predicting the prognosis of patients with cutaneous melanoma. Result: According to receiver operating characteristic (ROC) curves and area under the curve (AUC), the average accuracy of deep learning is higher than that of machine learning, and even the lowest accuracy is better than that of machine learning. Conclusion: As the number of learning increases, the accuracy of machine learning and deep learning will increase, but in the same number of cutaneous melanoma patient pathology maps, the accuracy of deep learning will be higher. This study provides new ideas and theories for computational pathology in predicting the prognosis of patients with cutaneous melanoma.

Indexed as

Deep LearningMelanomaSkin NeoplasmsCutaneous Malignant MelanomaHumansPrognosis

Identifiers

PMID36072469
PMCPMC9441353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.